Global General Anesthesia Drugs Market Growth 2019-2024

  • ID:PD041053
  • February 2019
  • LPI (LP Information)
                          

DecisionDatabases.com offers Global General Anesthesia Drugs Market Research Report with market statistics and future prospect for the year 2019-2024. This report explores historical data, market share, sales, consumption, revenue and market dynamic resulting in high quality and precise data. The future trend and outlook are analyzed and compiled with the help of industry experts. This report offers different segment analysis based on global, regional and country level along with key players with their revenue, sales, and strategic development. The data is gathered and analyzed  through primary and secondary research based on expert interviews, white papers, journals and various other sources.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. 

General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.

Europe is the largest supplier and consumption market of General Anesthesia Drugs, with a production market share of nearly 38% and sales market share nearly 32%. The second place is USA, following Europe with the production market share of 20% and the sales market share over 28%. Asia is another important market of General Anesthesia Drugs, enjoying 24% production market share and 25% sales market share.

According to this study, over the next five years the General Anesthesia Drugs market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 8170 million by 2024, from US$ 6500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in General Anesthesia Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the General Anesthesia Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  Propofol
  •  Etomidate
  •  Midazolam
  •  Sevoflurane
  •  Isoflurane
  •  Others
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  Intravenous Anesthetics
  •  Inhalational Anesthetics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Astrazeneca
  •  Fresenius-Kabi
  •  AbbVie
  •  Baxter Healthcare
  •  B.Braun
  •  Maruishi
  •  Piramal
  •  Hikma Pharmaceuticals
  •  Mylan
  •  Nhwa
  •  Hengrui
  •  Lunan

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global General Anesthesia Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of General Anesthesia Drugs market by identifying its various subsegments.
  •  Focuses on the key global General Anesthesia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the General Anesthesia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of General Anesthesia Drugs submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Anesthesia Drugs Consumption 2014-2024
2.1.2 General Anesthesia Drugs Consumption CAGR by Region
2.2 General Anesthesia Drugs Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Sevoflurane
2.2.5 Isoflurane
2.2.6 Others
2.3 General Anesthesia Drugs Consumption by Type
2.3.1 Global General Anesthesia Drugs Consumption Market Share by Type (2014-2019)
2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2014-2019)
2.3.3 Global General Anesthesia Drugs Sale Price by Type (2014-2019)
2.4 General Anesthesia Drugs Segment by Application
2.4.1 Intravenous Anesthetics
2.4.2 Inhalational Anesthetics
2.5 General Anesthesia Drugs Consumption by Application
2.5.1 Global General Anesthesia Drugs Consumption Market Share by Application (2014-2019)
2.5.2 Global General Anesthesia Drugs Value and Market Share by Application (2014-2019)
2.5.3 Global General Anesthesia Drugs Sale Price by Application (2014-2019)
 
3 Global General Anesthesia Drugs by Players
3.1 Global General Anesthesia Drugs Sales Market Share by Players
3.1.1 Global General Anesthesia Drugs Sales by Players (2017-2019)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Players (2017-2019)
3.2 Global General Anesthesia Drugs Revenue Market Share by Players
3.2.1 Global General Anesthesia Drugs Revenue by Players (2017-2019)
3.2.2 Global General Anesthesia Drugs Revenue Market Share by Players (2017-2019)
3.3 Global General Anesthesia Drugs Sale Price by Players
3.4 Global General Anesthesia Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global General Anesthesia Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 General Anesthesia Drugs by Regions
4.1 General Anesthesia Drugs by Regions
4.1.1 Global General Anesthesia Drugs Consumption by Regions
4.1.2 Global General Anesthesia Drugs Value by Regions
4.2 Americas General Anesthesia Drugs Consumption Growth
4.3 APAC General Anesthesia Drugs Consumption Growth
4.4 Europe General Anesthesia Drugs Consumption Growth
4.5 Middle East & Africa General Anesthesia Drugs Consumption Growth
 
5 Americas
5.1 Americas General Anesthesia Drugs Consumption by Countries
5.1.1 Americas General Anesthesia Drugs Consumption by Countries (2014-2019)
5.1.2 Americas General Anesthesia Drugs Value by Countries (2014-2019)
5.2 Americas General Anesthesia Drugs Consumption by Type
5.3 Americas General Anesthesia Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC General Anesthesia Drugs Consumption by Countries
6.1.1 APAC General Anesthesia Drugs Consumption by Countries (2014-2019)
6.1.2 APAC General Anesthesia Drugs Value by Countries (2014-2019)
6.2 APAC General Anesthesia Drugs Consumption by Type
6.3 APAC General Anesthesia Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe General Anesthesia Drugs by Countries
7.1.1 Europe General Anesthesia Drugs Consumption by Countries (2014-2019)
7.1.2 Europe General Anesthesia Drugs Value by Countries (2014-2019)
7.2 Europe General Anesthesia Drugs Consumption by Type
7.3 Europe General Anesthesia Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa General Anesthesia Drugs by Countries
8.1.1 Middle East & Africa General Anesthesia Drugs Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa General Anesthesia Drugs Value by Countries (2014-2019)
8.2 Middle East & Africa General Anesthesia Drugs Consumption by Type
8.3 Middle East & Africa General Anesthesia Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 General Anesthesia Drugs Distributors
10.3 General Anesthesia Drugs Customer
 
11 Global General Anesthesia Drugs Market Forecast
11.1 Global General Anesthesia Drugs Consumption Forecast (2019-2024)
11.2 Global General Anesthesia Drugs Forecast by Regions
11.2.1 Global General Anesthesia Drugs Forecast by Regions (2019-2024)
11.2.2 Global General Anesthesia Drugs Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global General Anesthesia Drugs Forecast by Type
11.8 Global General Anesthesia Drugs Forecast by Application
 
12 Key Players Analysis
12.1 Astrazeneca
12.1.1 Company Details
12.1.2 General Anesthesia Drugs Product Offered
12.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Astrazeneca News
12.2 Fresenius-Kabi
12.2.1 Company Details
12.2.2 General Anesthesia Drugs Product Offered
12.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Fresenius-Kabi News
12.3 AbbVie
12.3.1 Company Details
12.3.2 General Anesthesia Drugs Product Offered
12.3.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 AbbVie News
12.4 Baxter Healthcare
12.4.1 Company Details
12.4.2 General Anesthesia Drugs Product Offered
12.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Baxter Healthcare News
12.5 B.Braun
12.5.1 Company Details
12.5.2 General Anesthesia Drugs Product Offered
12.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 B.Braun News
12.6 Maruishi
12.6.1 Company Details
12.6.2 General Anesthesia Drugs Product Offered
12.6.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Maruishi News
12.7 Piramal
12.7.1 Company Details
12.7.2 General Anesthesia Drugs Product Offered
12.7.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Piramal News
12.8 Hikma Pharmaceuticals
12.8.1 Company Details
12.8.2 General Anesthesia Drugs Product Offered
12.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Hikma Pharmaceuticals News
12.9 Mylan
12.9.1 Company Details
12.9.2 General Anesthesia Drugs Product Offered
12.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Mylan News
12.10 Nhwa
12.10.1 Company Details
12.10.2 General Anesthesia Drugs Product Offered
12.10.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Nhwa News
12.11 Hengrui
12.12 Lunan
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Report 2019-2025

The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..